{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:36:07Z","timestamp":1790922967317,"version":"4.1.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2403,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      There have been several descriptions of mouse models that manifest select immunological and clinical features of autoimmune cholangitis with similarities to primary biliary cirrhosis in humans. Some of these models require immunization with complete Freund's adjuvant, whereas others suggest that a decreased frequency of T regulatory cells (Tregs) facilitates spontaneous disease. We hypothesized that antimitochondrial antibodies (AMAs) and development of autoimmune cholangitis would be found in mice genetically deficient in components essential for the development and homeostasis of forkhead box 3 (Foxp3)\n                      <jats:sup>+<\/jats:sup>\n                      Tregs. Therefore, we examined Scurfy (Sf) mice, animals that have a mutation in the gene encoding the Foxp3 transcription factor that results in a complete abolition of Foxp3\n                      <jats:sup>+<\/jats:sup>\n                      Tregs. At 3 to 4 weeks of age, 100% of animals exhibit high-titer serum AMA of all isotypes. Furthermore, mice have moderate to severe lymphocytic infiltrates surrounding portal areas with evidence of biliary duct damage, and dramatic elevation of cytokines in serum and messenger RNAs encoding cytokines in liver tissue, including tumor necrosis factor \u03b1, interferon-\u03b3, interleukin (IL)-6, IL-12, and IL-23.\n                      <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic>\n                      The lack of functional Foxp3 is a major predisposing feature for loss of tolerance that leads to autoimmune cholangitis. These findings reflect on the importance of regulatory T cells in other murine models as well as in patients with primary biliary cirrhosis. (Hepatology 2008.)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.22651","type":"journal-article","created":{"date-parts":[[2008,9,22]],"date-time":"2008-09-22T14:27:27Z","timestamp":1222093647000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":88,"title":["Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis #"],"prefix":"10.1097","volume":"49","author":[{"given":"Weici","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyr-Te","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Song","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Xiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Man","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20260311","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T cells: key controllers of immunologic selftolerance.","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"key":"R2-27-20260311","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work.","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R3-27-20260311","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4CD25 regulatory T cells.","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"R4-27-20260311","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.20032158","article-title":"Defective suppressor function of human CD4 CD25 regulatory T cells in autoimmune polyglandular syndrome type II.","volume":"199","author":"Kriegel","year":"2004","journal-title":"J Exp Med"},{"key":"R5-27-20260311","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by antiTNFalpha therapy.","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"key":"R6-27-20260311","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4()CD25() Tcells from patients with type 1 diabetes.","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"key":"R7-27-20260311","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4()CD25 T cells in the thymus of patients with autoimmune myasthenia gravis.","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"R8-27-20260311","doi-asserted-by":"crossref","first-page":"89195","DOI":"10.1155\/2007\/89195","article-title":"Regulatory T cells and human disease.","volume":"2007","author":"Cools","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"R9-27-20260311","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4CD25 regulatory T cells in health and autoimmune hepatitis.","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol"},{"key":"R10-27-20260311","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4CD25 regulatory T cells in patients with multiple sclerosis.","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"R11-27-20260311","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.20522","article-title":"Decreased FOXP3 levels in multiple sclerosis patients.","volume":"81","author":"Huan","year":"2005","journal-title":"J Neurosci Res"},{"key":"R12-27-20260311","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis.","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"R13-27-20260311","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","article-title":"The causes of primary biliary cirrhosis: convenient and inconvenient truths.","volume":"47","author":"Gershwin","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R14-27-20260311","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Livertargeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.","volume":"43","author":"Lan","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R15-27-20260311","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2006.04.005","article-title":"IL2 receptor alpha deficiency and features of primary biliary cirrhosis.","volume":"27","author":"Aoki","year":"2006","journal-title":"J Autoimmun"},{"key":"R16-27-20260311","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL2 receptor alpha() mice and the development of primary biliary cirrhosis.","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R17-27-20260311","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","article-title":"Ae2a,bdeficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis.","volume":"134","author":"Salas","year":"2008","journal-title":"Gastroenterology"},{"key":"R18-27-20260311","first-page":"1379","article-title":"Xlinked lymphoreticular disease in the scurfy (sf) mutant mouse.","volume":"138","author":"Godfrey","year":"1991","journal-title":"Am J Pathol"},{"key":"R19-27-20260311","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkheadwingedhelix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"R20-27-20260311","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.20050157","article-title":"The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis.","volume":"202","author":"Chang","year":"2005","journal-title":"J Exp Med"},{"key":"R21-27-20260311","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1073\/pnas.45.4.554","article-title":"Exceptional inheritance of a sexlinked gene in the mouse explained on the basis that the XO sexchromosome constitution is female.","volume":"45","author":"Russell","year":"1959","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-27-20260311","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaut.2006.11.003","article-title":"Novel animal models for Sjogrens syndrome: expression and transfer of salivary gland dysfunction from regulatory T celldeficient mice.","volume":"27","author":"Sharma","year":"2006","journal-title":"J Autoimmun"},{"key":"R23-27-20260311","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2249.2003.02217.x","article-title":"Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with Tenriched splenocytes.","volume":"133","author":"SmykPearson","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"R24-27-20260311","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.4049\/jimmunol.179.12.8035","article-title":"A novel role of IL2 in organspecific autoimmune inflammation beyond regulatory T cell checkpoint: both IL2 knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanisms.","volume":"179","author":"Zheng","year":"2007","journal-title":"J Immunol"},{"key":"R25-27-20260311","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/1521-4141(200101)31:1<196::AID-IMMU196>3.0.CO;2-9","article-title":"The murine mutation scurfy (sf) results in an antigendependent lymphoproliferative disease with altered T cell sensitivity.","volume":"31","author":"ZahorskyReeves","year":"2001","journal-title":"Eur J Immunol"},{"key":"R26-27-20260311","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.510240117","article-title":"Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.","volume":"24","author":"Moteki","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R27-27-20260311","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"Hepatology"},{"key":"R28-27-20260311","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaut.2007.07.021","article-title":"Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border.","volume":"29","author":"Lan","year":"2007","journal-title":"J Autoimmun"},{"key":"R29-27-20260311","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2008.03.002","article-title":"The regulatory, inflammatory, and T cell programming roles of interleukin2 (IL2).","volume":"31","author":"Lan","year":"2008","journal-title":"J Autoimmun"},{"key":"R30-27-20260311","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.autrev.2008.06.009","article-title":"Is autoimmunity a matter of sex?","volume":"7","author":"Lleo","year":"2008","journal-title":"Autoimmun Rev"},{"key":"R31-27-20260311","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaut.2007.06.003","article-title":"Autophagy: highlighting a novel player in the autoimmunity scenario.","volume":"29","author":"Lleo","year":"2007","journal-title":"J Autoimmun"},{"key":"R33-27-20260311","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.chom.2008.03.009","article-title":"Liver autoimmunity triggered by microbial activation of natural killer T cells.","volume":"3","author":"Mattner","year":"2008","journal-title":"Cell Host Microbe"},{"key":"R34-27-20260311","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment.","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"R35-27-20260311","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","article-title":"Frequency of monosomy X in women with primary biliary cirrhosis.","volume":"363","author":"Invernizzi","year":"2004","journal-title":"Lancet"},{"key":"R36-27-20260311","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cld.2008.02.011","article-title":"Animal models of primary biliary cirrhosis.","volume":"12","author":"Chuang","year":"2008","journal-title":"Clin Liver Dis"},{"key":"R37-27-20260311","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2007.02.003","article-title":"The X and why of xenobiotics in primary biliary cirrhosis.","volume":"28","author":"Rieger","year":"2007","journal-title":"J Autoimmun"},{"key":"R38-27-20260311","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2006.06.002","article-title":"Identification of 2nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis.","volume":"27","author":"Rieger","year":"2006","journal-title":"J Autoimmun"},{"key":"R39-27-20260311","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.179.4.2651","article-title":"Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization.","volume":"179","author":"Leung","year":"2007","journal-title":"J Immunol"},{"key":"R40-27-20260311","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.20010956","article-title":"Identification of HLAA2restricted CD8() cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes crosspresented by dendritic cells.","volume":"195","author":"Kita","year":"2002","journal-title":"J Exp Med"},{"key":"R41-27-20260311","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDCE2specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.","volume":"109","author":"Kita","year":"2002","journal-title":"J Clin Invest"},{"key":"R42-27-20260311","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/hep.22226","article-title":"Adoptive transfer of CD8() T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.","volume":"47","author":"Yang","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R43-27-20260311","first-page":"321","article-title":"The current immune function of hepatic dendritic cells.","volume":"4","author":"Hsu","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"R44-27-20260311","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1023\/A:1020511002025","article-title":"Cytokine profile in the liver of primary biliary cirrhosis.","volume":"19","author":"Nagano","year":"1999","journal-title":"J Clin Immunol"},{"key":"R45-27-20260311","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2249.1996.d01-759.x","article-title":"Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB).","volume":"105","author":"Shindo","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"R46-27-20260311","first-page":"89","article-title":"Increased expression of interleukin6 and tumor necrosis factoralpha in pathologic biliary epithelial cells: in situ and culture study.","volume":"78","author":"Yasoshima","year":"1998","journal-title":"Lab Invest"},{"key":"R47-27-20260311","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.4049\/jimmunol.169.12.6842","article-title":"The roles of IL12 in providing a third signal for clonal expansion of naive CD8 T cells.","volume":"169","author":"Valenzuela","year":"2002","journal-title":"J Immunol"},{"key":"R48-27-20260311","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0531-5565(03)00060-3","article-title":"The effect of IL12 on clinical and laboratory aspects of experimental SLE in young and aging mice.","volume":"38","author":"Segal","year":"2003","journal-title":"Exp Gerontol"},{"key":"R49-27-20260311","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-5728(96)00101-4","article-title":"Elevated serum levels of interleukin12 in chronic progressive multiple sclerosis.","volume":"70","author":"Nicoletti","year":"1996","journal-title":"J Neuroimmunol"},{"key":"R50-27-20260311","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-510X(96)05320-8","article-title":"Interleukin12 and tumor necrosis factoralpha levels in cerebrospinal fluid of multiple sclerosis patients.","volume":"147","author":"Drulovic","year":"1997","journal-title":"J Neurol Sci"},{"key":"R51-27-20260311","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI3125","article-title":"Elevated interleukin12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.","volume":"102","author":"Comabella","year":"1998","journal-title":"J Clin Invest"},{"key":"R52-27-20260311","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI31720","article-title":"APCderived cytokines and T cell polarization in autoimmune inflammation.","volume":"117","author":"Gutcher","year":"2007","journal-title":"J Clin Invest"},{"key":"R53-27-20260311","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1529-0131(199802)41:2<306::AID-ART15>3.0.CO;2-4","article-title":"Expression of interleukin12 in synovial tissue from patients with rheumatoid arthritis.","volume":"41","author":"Morita","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R54-27-20260311","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2005.11.016","article-title":"IL12 driven upregulation of Pselectin ligand on myelinspecific T cells is a critical step in an animal model of autoimmune demyelination.","volume":"173","author":"Deshpande","year":"2006","journal-title":"J Neuroimmunol"},{"key":"R55-27-20260311","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20080159","article-title":"IL12 and IL23modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.","volume":"205","author":"Kroenke","year":"2008","journal-title":"J Exp Med"},{"key":"R56-27-20260311","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Antimitochondrial antibodies and primary biliary cirrhosis in TGFbeta receptor II dominantnegative mice.","volume":"177","author":"Oertelt","year":"2006","journal-title":"J Immunol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22651","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200902000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:02:07Z","timestamp":1773252127000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200902000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22651","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}